Rare and There

Auteur(s): Amicus Therapeutics UK
Écouter gratuitement

  • Résumé

  • Understanding rare diseases, such as Fabry disease, can help reduce the diagnostic delay and improve management of the disease. This series explores Fabry disease in discussions with clinical experts who share their practical experience and patient perspectives to help bring Fabry onto the radar of healthcare providers.


    This podcast is initiated, organised and funded by Amicus Therapeutics and intended for healthcare professionals in the UK and is not intended to replace the need for medical consultations. Copyright 2024 Amicus Therapeutics. All rights reserved.


    NP-NN-UK-00031124 DOP: November 2024


    Hosted on Acast. See acast.com/privacy for more information.
    Amicus Therapeutics UK
    Voir plus Voir moins
Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2
Épisodes
  • Medical education for rare disease

    Medical education for rare disease
    Nov 19 2024

    Since many individuals with a rare disease can face years of delayed diagnosis and unnecessary testing, in the first episode of ‘Rare and There’, CEO of Medics4RareDiseases, Dr. Lucy McKay, covers why it is important for all medical professionals to learn about the basics of rare diseases to help further our understanding of the needs of the rare disease community, particularly regarding the impact on individuals and their relatives.


    This podcast was initiated, organised and funded by Amicus Therapeutics and is intended for healthcare professionals in UK. The views expressed reflect the experience and opinions of the speaker. Individual experiences may vary.


    NP-NN-UKI-00171024 (Date of preparation: October 2024)


    Hosted on Acast. See acast.com/privacy for more information.
    Voir plus Voir moins
    34 min

Ce que les auditeurs disent de Rare and There

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.